Digital Transformation

This evolution of healthcare involves using technology to improve diagnosis, treatments, monitor patients, enhance hospital operations and culture, and bolster consumer-focused care. This includes virtual reality tools, wearable devices, workflow software, health apps and other digital health tools.

Oracle reaches $100 million settlement with Oregon over failed exchange site

The state of Oregon paid $240 million for software giant Oracle to create the state’s Cover Oregon insurance exchange site, but the company will settle several lawsuits related to the site’s failure for just $100 million.

Pushing for a more connected ICU—without adding more alarms

Incentive care units may be critical departments in any hospital, but as STAT’s Usha Lee McFarling writes, they haven’t changed much in the past few decades.Unless you count adding more alarms.

CLARET MEDICAL SUBMITS MARKETING APPLICATION TO FDA FOR US CLEARANCE OF FIRST CEREBRAL PROTECTION SYSTEM FOR TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR)

SANTA ROSA, Calif. – September 20, 2016 – Claret Medical®, an innovator in filter-based cerebral embolic protection technologies, today announced its filing of a marketing application with the US Food and Drug Administration (FDA) for clearance of the Sentinel® Cerebral Protection System (CPS).

Integer Announces Planned Departure of Chief Financial Officer

FRISCO, Texas, Sept. 14, 2016 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource (MDO) manufacturer, today announced that Michael Dinkins, executive vice president and chief financial officer, plans to leave the Company. The Company has commenced a search for his successor, and Mr. Dinkins will continue to serve as executive vice president and chief financial officer for up to six months or such earlier date when his successor is named.

Health IT firm develops system to track, share info on hackers

Ransomware has developed into a growing infection for the medical industry, except that healthcare providers can’t treat these problems so easily. In an effort to fight data-stealing hackers, MedCrypt has recently raised $750,000 to develop new means of protection.

Aphios to Develop HIV/AIDS Cure Using Combination Drugs in Targeted ‘Nanosomes’ Nanoparticles

WOBURN, Mass.--(BUSINESS WIRE)--Aphios Corporation today announced that it plans to continue its research to develop a cure for HIV/AIDS using combination drugs in targeted ‘nanosomes’ nanoparticles with recent funding from the National Institute of Allergy and Infectious Diseases (NIAID), NIH.

New Study Shows Innovative Zip Skin Closure System Saves Time in the Cath Lab

CAMPBELL, Calif. – September 7, 2016 – ZipLine® Medical, Inc., an innovator in skin closure, today announced results from a study recently published online in Pacing and Clinical Electrophysiology (PACE) showing significant efficiencies when Zip® Surgical Skin Closure is used following cardiac implantable electronic device (CIED) implantation. The Zip also demonstrated greater uniformity in closure technique, with no compromise in cosmetic outcomes or patient safety. 

LA County Department of Health Services Selects Cerner’s Population Health Management Platform

LOS ANGELES, Sept. 07, 2016 (GLOBE NEWSWIRE) -- The Los Angeles County Department of Health Services (LACDHS), in collaboration with the California PRIME Project (1115 MediCal waiver), has expanded its relationship with Cerner, a global leader in health care technology, to implement its population health management platform,HealtheIntentSM. LACDHS is Cerner’s 100th HealtheIntent client.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.